WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY

Saved in:

Bibliographic Details
Main Authors:	Mateus Luvizotto, Renato Monteiro, Niels Olsen Camara, Luis Yu, Cristiane Bitencourt Dias, Lecticia Barbosa Jorge, Viktoria Woronik
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924003607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of JAK/STAT signal pathway in IgA nephropathy and its prospects of treatment
by: Ci Xin, et al.
Published: (2021-01-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2024-02-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY
by: Kazuaki Mori, et al.
Published: (2025-02-01)

WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING
by: Meghana Rao C, et al.
Published: (2025-02-01)

WCN24-889 BASILIXIMAB INDUCTION, STEROID USE AND RECURRENCE OF IGA NEPHROPATHY IN RENAL TRANSPLANT PATIENTS
by: Isabela Bertoni, et al.
Published: (2024-04-01)

WCN24-1347 CLINICAL PRESENTATION AT THE TIME OF DIAGNOSIS IN A COHORT OF MEXICAN PATIENTS WITH IGA NEPHROPATHY
by: Estefania Garduño Hernandez, et al.
Published: (2024-04-01)

WCN24-2270 COMPLEMENT SYSTEM IS OVERACTIVATED IN PATIENTS WITH IGA NEPHROPATHY AFTER COVID-19 INFECTION
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN24-1383 ADHERENCE TO INTERNATIONAL GUIDELINES FOR THE TREATMENT OF A COHORT OF MEXICAN PATIENTS WITH IGA NEPHROPATHY
by: Estefania Garduño Hernandez, et al.
Published: (2024-04-01)

WCN25-4505 A DESCRIPTIVE STUDY ON THE CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF IgA NEPHROPATHY USING THE INTERNATIONAL IgA NEPHROPATHY PREDICTION TOOL
by: Arghya Chakraborty, et al.
Published: (2025-02-01)

WCN24-1121 Novel IgA type autoantibodies against mesangial autoantigen, βIIspectrin, are specifically detected in patients with IgA nephropathy
by: Kazuaki Mori, et al.
Published: (2024-04-01)

WCN24-943 CASE REPORT: CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENT DEVELOPED PROGRESSIVE CHRONIC KIDNEY DISEASE CAUSED BY LYSOZYME-INDUCED NEPHROPATHY
by: Isis De Vito Izzo Ferreira, et al.
Published: (2024-04-01)

JAK/STAT signaling in hepatocellular carcinoma
by: Justin Jit Hin Tang, et al.
Published: (2020-03-01)

JAK-STAT Signaling in Autoimmunity and Cancer
by: Parveen S, et al.
Published: (2025-05-01)

WCN24-2062 CLINICOPATHOLOGICAL CHARACTERISTICS AND LONG-TERM PROGNOSIS OF IgA NEPHROPATHY PATIENTS WITH NEPHROTIC SYNDROME
by: xiaoling zhou, et al.
Published: (2024-04-01)

WCN24-733 Treatment decision-making modle for IgA nephropathy: a real-world study
by: Ying Zheng, et al.
Published: (2024-04-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY
by: MANJARI BHAT, et al.
Published: (2025-02-01)

WCN24-2601 RARITY OF IGA NEPHROPATHY IN AFRICA: EVIDENCE FROM A 10YEAR REVIEW OF RENAL BIOPSIES IN EAST AFRICA - A POINTER TO THE GEOGRAPHICAL AND RACIAL DISPARITY OF IGA NEPHROPATHY IN AFRICA
by: Ahmed Kalebi
Published: (2024-04-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

WCN24-743 BLIND SPOT IN THE RADAR OF MEST-C SCORE: TYPE AND SEVERITY OF TUBULOINTERSTITIAL NEPHRITIS IN IGA NEPHROPATHY
by: Aurangzeb Afzal, et al.
Published: (2024-04-01)

WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN25-4245 A CASE SERIES OF CONCURRENT IGA NEPHROPATHY AND ANTI- GBM DISEASE
by: Priyangani Lohia, et al.
Published: (2025-02-01)

WCN25-4132 IL-31 and JAK-STAT Signaling in CKD-aP: Exploring Therapeutic Implication
by: Mohinder Kaur, et al.
Published: (2025-02-01)

Is Childhood IgA Nephropathy Different From Adult IgA Nephropathy? A Narrative Review
by: Areefa Alladin-Karan, et al.
Published: (2025-03-01)

WCN24-2599 EFFICACY AND SAFETY OF BUDESONIDE IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: João Lucas de Magalhães Leal Moreira, et al.
Published: (2024-04-01)

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY
by: Hernán Trimarchi, et al.
Published: (2024-04-01)

Exploration of JAK/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2/STAT3 in the inflammatory response
by: Cristina Calviño-Suárez, et al.
Published: (2025-07-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-2007 Evaluation of treatment strategy in patients with IgA nephropathy with impaired renal function
by: Ryousuke Aoki, et al.
Published: (2025-02-01)

WCN25-1387 DIFFUSE ALVEOLAR HEMORRHAGE AS AN ATYPICAL PRESENTATION FOR IgA NEPHROPATHY: CASE REPORT
by: José Fidel Véliz Escobar, et al.
Published: (2025-02-01)

WCN25-2980 ELECTROLYTE IMBALANCE AS A PRESENTING FEATURE IN IGA NEPHROPATHY: A CASE REPORT
by: Zafirah Zahir, et al.
Published: (2025-02-01)

WCN25-892 RARE CASE OF PRTOEINURIC IGA NEPHROPATHY IN A PATIENT WITH IDIOPATHIC INTRACRANIAL HYPERTENSION
by: Sutanay Bhattacharyya
Published: (2025-02-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Unconventional T Cells in IgA Nephropathy
by: Zizhang Sheng, et al.
Published: (2025-02-01)

Corrigendum to “Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review”
Published: (2025-07-01)